Targeted tumor gene therapy based on loss of IGF2 imprinting

Loss of imprinting (LOI) of the insulin-like growth factor 2 gene (IGF2) is one of the most common epigenetic abnormalities seen in human neoplasms. LOI may be associated with the lack of Zinc-finger DNA binding protein CTCF-mediated enhancer insulation, presumably due to the gain of methylation on...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pan, Yuqin, He, Bangshun, Li, Tao, Zhu, Chan, Zhang, Lirong, Wang, Bo, Xu, Yongfei, Qu, Lili, Hoffman, Andrew R, Wang, Shukui, Hu, Jifan
Format:	Artigo
Language:	Inglês
Published:	Landes Bioscience 2010
Subjects:	Research Paper
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3040838/ https://ncbi.nlm.nih.gov/pubmed/20592487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.10.3.12442
Tags:	Add Tag No Tags, Be the first to tag this record!

Targeted tumor gene therapy based on loss of IGF2 imprinting

Similar Items